Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FAP”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06082050
What this trial is testing

Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy

Who this might be right for
Transthyroxin Amyloidosis Cardiomyopathy
Zhejiang University 7
Large-scale testing (Phase 3)WithdrawnNCT01245816
What this trial is testing

A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)

Who this might be right for
Familial Adenomatous Polyposis
Cancer Prevention Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00503035
What this trial is testing

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Who this might be right for
Familial Adenomatous Polyposis
M.D. Anderson Cancer Center 51
Not applicableLooking for participantsNCT07654855
What this trial is testing

Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations

Who this might be right for
Transthyretin AmyloidosisTransthyretin Amyloidosis With CardiomyopathyTransthyretin Amyloidosis With Polyneuropathy
AstraZeneca 320
Not applicableUnknownNCT05754099
What this trial is testing

Identification of Clinically Significant Markers of ATTRv in Pre-symptomatic Mutation Carriers.

Who this might be right for
Amyloidosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Testing effectiveness (Phase 2)Study completedNCT01187901
What this trial is testing

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients

Who this might be right for
Adenomatous Polyposis Coli
University of Utah 92
Not applicableStudy completedNCT04276220
What this trial is testing

Prevalence of wtATTR-CM After Carpal Tunnel Release Surgery

Who this might be right for
Transthyretin AmyloidosisTransthyretin Cardiac AmyloidosisWild-Type Transthyretin-Related (ATTR)Amyloidosis
Steen Hvitfeldt Poulsen 109
Not applicableUnknownNCT04709445
What this trial is testing

Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses

Who this might be right for
Bowel ObstructionBowel IschemiaDiverticulitis+9 more
Charite University, Berlin, Germany 100
Not applicableLooking for participantsNCT06349512
What this trial is testing

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)

Who this might be right for
Triple Negative Breast Cancer
Institut Curie 60
Early research (Phase 1)Study completedNCT06973005
What this trial is testing

Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants

Who this might be right for
Advanced Chronic Liver DiseaseHealthy Participants
AstraZeneca 16
Testing effectiveness (Phase 2)UnknownNCT05515783
What this trial is testing

68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies

Who this might be right for
Tumor
First Affiliated Hospital of Fujian Medical University 50
Not applicableStudy completedNCT04990882
What this trial is testing

FAPI PET/CT Prospective Interobserver Agreement

Who this might be right for
Malignant Neoplasm
University Hospital, Essen 15
Testing effectiveness (Phase 2)Looking for participantsNCT04939610
What this trial is testing

177Lu-FAP-2286 in Advanced Solid Tumors

Who this might be right for
Solid Tumor
Novartis Pharmaceuticals 222
Not applicableLooking for participantsNCT06465810
What this trial is testing

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Who this might be right for
Transthyretin AmyloidosisATTR-CMATTRv-PN+3 more
AstraZeneca 1,850
Not applicableLooking for participantsNCT07498933
What this trial is testing

FAP-targeted PET/NIR in Lung Malignant Tumors

Who this might be right for
Non-Small Cell Lung CancerPET/CTNeoadjuvant Therapy
Peking University People's Hospital 200
Early research (Phase 1)Not Yet RecruitingNCT07729371
What this trial is testing

A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).

Who this might be right for
Familial Adenomatous Polyposis (FAP)
Sapience Therapeutics 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06712030
What this trial is testing

Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction

Who this might be right for
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Puerta de Hierro University Hospital 114
Not applicableUnknownNCT03098901
What this trial is testing

Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease

Who this might be right for
Cardiac TTR Amyloidosis
Kaplan Medical Center 100
Not applicableLooking for participantsNCT05873777
What this trial is testing

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

Who this might be right for
SSTR2FAPPositron-Emission Tomography
The First Affiliated Hospital of Xiamen University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07434180
What this trial is testing

Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary

Who this might be right for
Cancer of Unknown Primary
Peter MacCallum Cancer Centre, Australia 20
Next Page